Table 2.
The relationship between laboratory findings and histopathological type and advanced- stage (TNM) in lung cancer group.
| Histopathological Type (p Value) | Advanced- Stage (TNM) (p Value) | |
|---|---|---|
| Plt, ×10³/μL | 0.23 | 0.02 * |
| MPV, fL | 0.46 | 0.04 * |
| PCT, % | 0.33 | 0.01 * |
| PDW, % | 0.53 | 0.06 |
| Neutrophile, μL | 0.47 | 0.09 |
| Lymphocyte, μL | 0.49 | 0.02 * |
| NLR | 0.59 | 0.03 * |
| PLR | 0.34 | 0.001 * |
| Total protein, g/L | 0.87 | 0.82 |
| Albumin, g/L | 0.16 | 0.02 * |
| Total Cholesterol, mmol/L | 0.55 | 0.34 |
| Triglyceride, mmol/L | 0.32 | 0.76 |
| HDL, mmol/L | 0.80 | 0.001 * |
| LDL, mmol/L | 0.60 | 0.98 |
| VLDL, mmol/L | 0.40 | 0.60 |
| CRP, mg/L | 0.78 | 0.004 * |
* Statistically significant, p < 0.05; PLT, platelet; PDW, platelet distribution width; MPV, mean platelet volüme; PCT, plateletcrit; CRP, C-reactive protein; HDL, high-density lipoprotein; LDL, low-density lipoprotein; VLDL, very low-density lipoprotein; NLR, neutrophile/lymphocyte ratio; PLR, platelet/lymphocyte ratio.